ACCEL Lite: Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

<p class="MsoNormal">What are the practical considerations when determining the duration of antiplatelet regimens following PCI? </p> <p class="MsoNormal">In this interview, Mirvat Alasnag, FACP, FACC, FSCAI, FSCCT, and Sun Moon Kim, MD, FSCAI, FACC, discuss Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI? </p> <p class="MsoNormal"><a href= "https://itunes.apple.com/us/podcast/eagles-eye-view-your-weekly-cv-update-from-acc-org/id1274635046" target="_blank" rel="noopener">Subscribe on Apple</a> <u>Podcasts</u> | <a href= "https://play.google.com/music/listen#/ps/I6dtkumvaipematzgzmbph2koiq" target="_blank" rel="noopener">Subscribe on Google Play</a> <u>|</u> <a href= "http://www.acc.org/education-and-meetings/products-and-resources/accel-audio" target="_blank" rel="noopener">Subscribe to ACCEL</a> </p>